Free Trial

Sonova (OTCMKTS:SONVY) Stock Price Crosses Below 50 Day Moving Average - Should You Sell?

Sonova logo with Medical background

Sonova Holding AG (OTCMKTS:SONVY - Get Free Report)'s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $67.86 and traded as low as $65.02. Sonova shares last traded at $65.40, with a volume of 54,701 shares traded.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Citigroup raised Sonova to a "strong sell" rating in a research report on Thursday, November 21st. The Goldman Sachs Group raised shares of Sonova to a "strong sell" rating in a research report on Tuesday, October 22nd. Finally, Barclays lowered shares of Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, November 20th.

Get Our Latest Stock Analysis on Sonova

Sonova Trading Up 0.5 %

The firm has a 50-day simple moving average of $67.86 and a two-hundred day simple moving average of $67.86. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.45 and a quick ratio of 1.07.

About Sonova

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Featured Articles

Should You Invest $1,000 in Sonova Right Now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines